These effects, together with a prior report showing that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,2 aid the principle of targeting ACKR3 as a unique approach to modulate the opioid system, which could open up new therapeutic avenues for opioid-linked disorders. (two) The health practitioner has https://jamesk472byf9.wikiconverse.com/user